MEET OUR MANAGEMENT TEAM

Research with passion. We are a team of dedicated scientists and economists who have made it their goal to demonstrably improve people’s quality of life with every product we develop.

Dr. Tobias Meller
Dr. Tobias MellerChief Executive Officer
After obtaining his doctorate in the field of technical chemistry, Tobias Meller was working as a research engineer in a major chemical company. Now, it is his duty to fulfill the technical vision of TINY Technologies. This includes development and optimization of the TINY product portfolio as well as the production thereof.
Tobias Münnich
Tobias MünnichChief Commercial Officer
Tobias Münnich has many years of experience in national and international sales. His focus is on pharmaceutical preparations and dietary supplements. At TINY Technologies he is responsible for the development of strategic partnerships and operational business development.
Dr. Sung-Min Pyo
Dr. Sung-Min PyoChief Technology Officer
As a passionate pharmacist and innovative scientist in the field of drug delivery and formulation development, Sung Min has made it her mission to put her expertise, skills and creativity at the service of significantly improving patients’ quality of life.
Oliver Drozdalski
Oliver DrozdalskiChief Laboratory Officer
Oliver Drozdalski is a passionate researcher and developer. His focus is on safety engineering and process validation. Oliver is therefore responsible for all operational research topics.

Advisor

Patrick Pehmöller
Patrick PehmöllerBusiness Angel
Since 2011, Patrick Pehmöller has founded six Tech-Startups himself and participated in several others as a business angel. Patrick acts as an interface for interdisciplinary issues and investor relations.
Dr. Massimiliano Pio di Cagno
Dr. Massimiliano Pio di CagnoAcademic Advisor R&D
Dr. di Cagno works as an associate professor in pharmacy at the University of Oslo (Norway). His research focus is in physical pharmacy, where he has decided expertise in the development of pharmaceutical preformulations. In particular, he focuses on the correlation of in vitro/in silico methods to predict the in vivo behavior of drugs and pharmaceutical formulations.

SCIENCE IS IN OUR DNA